Summary
The AVOREN trial was conducted to compare interferon alone with interferon plus bevacizumab for the treatment of metastatic renal cell carcinoma (RCC). The findings of the trial represent an important step in the recent advances in the treatment of RCC.
- Oncology Clinical Trials
- Gastrointestinal Cancers
- © 2007 MD Conference Express
Tools
A Randomized, Controlled, Double-Blind Phase 3 Study of Bevacizumab/Interferon-α2a vs Placebo/Interferon- α2a as First-line Therapy in Metastatic Renal Cell Carcinoma
Permalink:
Table of contents
Cited By...
- No citing articles found.